Ajay Royan has bought stock on 2 days since Aug 2021

Ajay Royan is a director and significant shareholder (over 10%) of Fractyl Health, Inc. (NASDAQ: GUTS), where he serves on the board and participates in the company’s long‑term ownership and governance.( In June 2026, he acquired 23,000 shares of Fractyl Health common stock in an open‑market transaction, bringing his direct holdings to 40,901 shares, in addition to substantial indirect beneficial ownership through Mithril investment entities.( He also serves on the boards of other growth‑stage technology and life sciences companies, including Invivyd Inc., reflecting his role as an active corporate insider and governance leader.(

Royan is the founder and managing general partner of Mithril Capital Management, a global technology investment firm that makes concentrated, long‑term investments in transformative and durable technology companies across sectors such as cybersecurity, advanced medical devices, and fusion energy.( Under his leadership, Mithril has been an early investor and strategic partner to companies including Fractyl Health and other technology pioneers, emphasizing durable growth and competitive strategy.( Prior to founding Mithril, Royan was a macro and growth equity investor and a member of the core team that grew Clarium Capital into a multibillion‑dollar macro fund.( He serves on scientific and policy advisory bodies, including the Science Advisory Board of Oak Ridge National Laboratory and the Board of Directors of Fulbright Canada, and was educated at Yale University, where he earned his B.A.(

Written by Perplexity from public sources.